CAPN8 involves with exhausted, inflamed, and desert immune microenvironment to influence the metastasis of thyroid cancer

Abstract

BackgroundThyroid cancer (THCA) is the most prevalent malignant disease of the endocrine system, in which 5-year survival can attain about 95%, but patients with metastasis have a poor prognosis. Very little is known about the role of CAPN8 in the metastasis of THCA. In particular, the effect of CAPN8 on the tumor immune microenvironment (TIME) and immunotherapy response is unclear.Material and methodsMultiome datasets and multiple cohorts were acquired for analysis. Firstly, the expression and the prognostic value of CAPN8 were explored in public datasets and in vitro tumor tissues. Then, hierarchical clustering analysis was performed to identify the immune subtypes of THCA according to the expression of CAPN8 and the activities of related pathways. Subsequent analyses explored the different patterns of TIME, genetic alteration, DNA replication stress, drug sensitivity, and immunotherapy response among the three immune phenotypes. Finally, five individual cohorts of thyroid cancer were utilized to test the robustness and extrapolation of the three immune clusters.ResultsCAPN8 was found to be a significant risk factor for THCA with a markedly elevated level of mRNA and protein in tumor tissues. This potential oncogene could induce the activation of epithelial–mesenchymal transition and E2F-targeted pathways. Three subtypes were identified for THCA, including immune exhausted, inflamed, and immune desert phenotypes. The exhausted type was characterized by a markedly increased expression of inhibitory receptors and infiltration of immune cells but was much more likely to respond to immunotherapy. The immune desert type was resistant to common chemotherapeutics with extensive genomic mutation and copy number variance.ConclusionThe present study firstly explored the role of CAPN8 in the metastasis of THCA from the aspects of TIME. Three immune subtypes were identified with quite different patterns of prognosis, immunotherapy response, and drug sensitivity, providing novel insights for the treatment of THCA and helping understand the cross-talk between CAPN8 and tumor immune microenvironment.

TRIM Expression in HNSCC: Exploring the Link Between Ubiquitination, Immune Infiltration, and Signaling Pathways Through Bioinformatics

“…Numerous studies have confirmed that tumor immune cell infiltration could influence the efficacies of chemotherapy, radiotherapy, or immunotherapy as well as metastasis, such as ovarian tumor, neuroblastoma, and so on. [42][43][44][45] Our results suggested that the four TRIMs are positively correlated with CD4 + T cells and macrophages. CD4 + T cells and tumor-associated macrophages could participate in tumor development via many signaling pathways, such as the Wnt and NF-κB signaling pathways.…”

Knowledge mapping of immunotherapy for thyroid cancer from 1980 to 2022: A review

“…[70] In recent years, immunotherapy has been extensively used in cancer treatment including TC. [26,[71][72][73][74][75][76][77][78][79][80][81] In this study, papers on immunotherapy for TC were studied by using bibliometric method.…”

“…The size of the font indicates the frequency. The top 10 keywords are: immunotherapy (232), thyroid cancer (76), radioimmunotherapy (70), immune checkpoint inhibitors (54), cancer (41), nivolumab (37), anaplastic thyroid cancer (33), prognosis (33). Figure 6B shows the thematic evolution map.…”

Genetic requirement ofdact1/2to regulate noncanonical Wnt signaling andcalpain 8during embryonic convergent extension and craniofacial morphogenesis

“…Our findings also warrant investigation into the role of capn8 during embryogenesis and possible implications for known craniofacial or other disorders. Recently, Capn8 has been implicated in EMT associated with cancer metastasis (Zhong, Xu et al 2022, Song, Cui et al 2024) and Xenopus capn8 was found to be required for CNCC migration (Cousin, Abbruzzese et al 2011). Together these findings support a role of capn8 in CNCC migration and craniofacial morphogenesis.…”